In addition, PASK deficiency provides protection from high fat diet-induced obesity and insulin resistance by affecting the expression or activation of enzymes and receptors involved in fat synthesis and increasing mitochondrial respiration, implying that PASK may become a potential target for the treatment of MetS. Here, PASK is linked to metabolic syndrome.